Patients in the mild SCH-LT4 group showed a marginally significant reduction in serum ALT from 19.09 IU/L to 17.95 IU/L (p = 0.087), whereas serum ALT in the mild SCH-control group was quite stable in the study. This evidence concerns the gene GPT and spindle cell hemangioma.